These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19393249)

  • 1. NBN 657del5 heterozygous mutations and colorectal cancer risk in the Czech Republic.
    Pardini B; Naccarati A; Polakova V; Smerhovsky Z; Hlavata I; Soucek P; Novotny J; Vodickova L; Tomanova V; Landi S; Vodicka P
    Mutat Res; 2009 Jun; 666(1-2):64-7. PubMed ID: 19393249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer risk of heterozygotes with the NBN founder mutation.
    Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
    J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heterozygous carriers of Slavic mutation 657del5 of NBN gene in patients with colorectal cancer].
    Seemanová E; Hoch J; Seeman P
    Cas Lek Cesk; 2011; 150(2):97-9. PubMed ID: 21560448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours.
    Nowak J; Mosor M; Ziółkowska I; Wierzbicka M; Pernak-Schwarz M; Przyborska M; Roznowski K; Pławski A; Słomski R; Januszkiewicz D
    Eur J Cancer; 2008 Mar; 44(4):627-30. PubMed ID: 18280732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
    Hebbring SJ; Fredriksson H; White KA; Maier C; Ewing C; McDonnell SK; Jacobsen SJ; Cerhan J; Schaid DJ; Ikonen T; Autio V; Tammela TL; Herkommer K; Paiss T; Vogel W; Gielzak M; Sauvageot J; Schleutker J; Cooney KA; Isaacs W; Thibodeau SN
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):935-8. PubMed ID: 16702373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical variability and expression of the NBN c.657del5 allele in Nijmegen Breakage Syndrome.
    Lins S; Kim R; Krüger L; Chrzanowska KH; Seemanova E; Digweed M
    Gene; 2009 Nov; 447(1):12-7. PubMed ID: 19635536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations.
    Varon R; Seemanova E; Chrzanowska K; Hnateyko O; Piekutowska-Abramczuk D; Krajewska-Walasek M; Sykut-Cegielska J; Sperling K; Reis A
    Eur J Hum Genet; 2000 Nov; 8(11):900-2. PubMed ID: 11093281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer.
    Roznowski K; Januszkiewicz-Lewandowska D; Mosor M; Pernak M; Litwiniuk M; Nowak J
    Breast Cancer Res Treat; 2008 Jul; 110(2):343-8. PubMed ID: 17899368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygous germ-line mutations in the NBN gene predispose to medulloblastoma in pediatric patients.
    Ciara E; Piekutowska-Abramczuk D; Popowska E; Grajkowska W; Barszcz S; Perek D; Dembowska-Bagińska B; Perek-Polnik M; Kowalewska E; Czajńska A; Syczewska M; Czornak K; Krajewska-Walasek M; Roszkowski M; Chrzanowska KH
    Acta Neuropathol; 2010 Mar; 119(3):325-34. PubMed ID: 19908051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
    Polakova V; Pardini B; Naccarati A; Landi S; Slyskova J; Novotny J; Vodickova L; Bermejo JL; Hanova M; Smerhovsky Z; Tulupova E; Kumar R; Hemminki K; Vodicka P
    Hum Mutat; 2009 Apr; 30(4):661-8. PubMed ID: 19224585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Slavic NBN Founder Mutation: A Role for Reproductive Fitness?
    Seemanova E; Varon R; Vejvalka J; Jarolim P; Seeman P; Chrzanowska KH; Digweed M; Resnick I; Kremensky I; Saar K; Hoffmann K; Dutrannoy V; Karbasiyan M; Ghani M; Barić I; Tekin M; Kovacs P; Krawczak M; Reis A; Sperling K; Nothnagel M
    PLoS One; 2016; 11(12):e0167984. PubMed ID: 27936167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland.
    Steffen J; Varon R; Mosor M; Maneva G; Maurer M; Stumm M; Nowakowska D; Rubach M; Kosakowska E; Ruka W; Nowecki Z; Rutkowski P; Demkow T; Sadowska M; Bidziński M; Gawrychowski K; Sperling K
    Int J Cancer; 2004 Aug; 111(1):67-71. PubMed ID: 15185344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis.
    Dumon-Jones V; Frappart PO; Tong WM; Sajithlal G; Hulla W; Schmid G; Herceg Z; Digweed M; Wang ZQ
    Cancer Res; 2003 Nov; 63(21):7263-9. PubMed ID: 14612522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nijmegen Breakage Syndrome mutations and risk of breast cancer.
    Bogdanova N; Feshchenko S; Schürmann P; Waltes R; Wieland B; Hillemanns P; Rogov YI; Dammann O; Bremer M; Karstens JH; Sohn C; Varon R; Dörk T
    Int J Cancer; 2008 Feb; 122(4):802-6. PubMed ID: 17957789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nijmegen breakage syndrome (NBS) with neurological abnormalities and without chromosomal instability.
    Seemanová E; Sperling K; Neitzel H; Varon R; Hadac J; Butova O; Schröck E; Seeman P; Digweed M
    J Med Genet; 2006 Mar; 43(3):218-24. PubMed ID: 16033915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygosity for the BLM(Ash) mutation and cancer risk.
    Cleary SP; Zhang W; Di Nicola N; Aronson M; Aube J; Steinman A; Haddad R; Redston M; Gallinger S; Narod SA; Gryfe R
    Cancer Res; 2003 Apr; 63(8):1769-71. PubMed ID: 12702560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mutations in tumor suppressor gene NBS1 in adult patients with malignancies].
    Seemanová E; Hoch J; Herzogová J; Kawaciuk I; Janda J; Kohoutová M; Seeman P; Varon R; Sperling K
    Cas Lek Cesk; 2006; 145(3):201-3. PubMed ID: 16634478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of MYH gene in genetic predisposition to colorectal cancer: another piece of the puzzle.
    Avezzù A; Agostini M; Pucciarelli S; Lise M; Urso ED; Mammi I; Maretto I; Enzo MV; Pastrello C; Lise M; Nitti D; Viel A
    Cancer Lett; 2008 Sep; 268(2):308-13. PubMed ID: 18495334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of gastrointestinal lymphoma in carriers of the 657del5 NBS1 gene mutation.
    Steffen J; Maneva G; Popławska L; Varon R; Mioduszewska O; Sperling K
    Int J Cancer; 2006 Dec; 119(12):2970-3. PubMed ID: 16998789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population.
    Kleibl Z; Havranek O; Hlavata I; Novotny J; Sevcik J; Pohlreich P; Soucek P
    Eur J Cancer; 2009 Mar; 45(4):618-24. PubMed ID: 18996005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.